Rutgers Cancer Institute of New Jersey
195 Little Albany Street
New Brunswick, NJ 08903-2681
Today's treatments are tomorrow's cures. The Cancer Institute of New Jersey's physician-scientists work together to bring the most innovative clinical trials to our patients. As an NCI-designated Comprehensive Cancer Center, patients have access to treatment options that may not be available elsewhere.
Clinical trials are research studies in which patients may volunteer to take part. Rutgers Cancer Institute of New Jersey uses clinical trials to find better ways to prevent, diagnose and treat cancer. As one of the National Cancer Institute’s designated cancer centers, Rutgers Cancer Institute of New Jersey is able to provide access to clinical trials not available at other hospitals, clinics or doctor’s offices, as well as access to some of the most advanced, targeted treatments and medicines available. Rutgers Cancer Institute of New Jersey is committed to providing the latest and best treatment options for cancer patients through clinical trials - outsmarting cancer with science.
All of today’s successful treatments for cancer are based on results of past clinical trials. Because of progress made through clinical trials, people treated for cancer are living longer today. Rutgers Cancer Institute currently enrolls approximately 17 percent of all its new adult cancer patients and approximately 70 percent of all pediatric cancer patients on clinical trials. Enrollment in clinical trials nationwide is fewer than five percent of all adult cancer patients.
Learn about clinical trials with Rutgers Cancer Institute's Eric Singer, MD, MA